Although CXCL10-specific effects against glioma associated with celecoxib treatment might differ depending on the circumstances7, we observed that increased levels of CXCL10+ cells in the tumor and peri-tumor, and that CXCL10 levels decreased following treatment with celecoxib in our glioma model. Here, CXCL10 is linked to central nervous system cancer.